CUAMC
LFCR icon

China Universal Asset Management Company’s Lifecore Biomedical LFCR Stock Holding History

China Universal Asset Management Company’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.3K Sell
5,970
-679
-10% -$3.42K ﹤0.01% 483
2026
Q1 		$24.7K Buy
6,649
+544
+9% +$3.76K ﹤0.01% 490
2025
Q4 		$49.9K Buy
+6,105
New +$45.2K ﹤0.01% 452

Other funds holding LFCR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $292M AUM 36.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CA
CWC Advisors Lake Oswego, Oregon $225M AUM 23.94% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

China Universal Asset Management Company's LFCR Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Lifecore Biomedical (LFCR) stake by 10% in Q2 2026, selling an estimated $3.42K and leaving 5,970 shares worth $31.3K. The position accounts for ﹤0.01% of the portfolio, ranked #483.

China Universal Asset Management Company first reported a position in LFCR in Q4 2025 and has held it in 3 quarters since. The position peaked at $49.9K in Q4 2025. 51 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • China Universal Asset Management Company held 5,970 shares of Lifecore Biomedical worth $31.3K as of Q2 2026.
  • China Universal Asset Management Company sold 679 Lifecore Biomedical shares in Q2 2026, an estimated $3.42K.
  • Lifecore Biomedical made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #483 holding.
  • China Universal Asset Management Company first reported a position in Lifecore Biomedical in Q4 2025 and has held it in 3 quarters since.
  • China Universal Asset Management Company's Lifecore Biomedical position peaked at $49.9K in Q4 2025.
  • 51 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.